Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/wAr1SjISHnI/220319.php
Monday, March 28, 2011
New Interim Data About Combination Oral Contraceptives
Bayer HealthCare Pharmaceuticals Inc. announced that interim results from a large, prospective, observational cohort safety study offer insights into the increased risk of venous thromboembolism (VTE), or blood clots, which is a well-established risk in women who use combination oral contraceptives (COCs), also known as "the Pill". Specifically, the new data provides healthcare providers with information regarding when the VTE risk associated with COCs is highest...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment